About 8 results found for searched term "BCL6-IN-6" (0.122 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M15107 | BCL6-IN-6 | Others |
| BCL6-IN-6 is a potent inhibitor of transcriptional suppressor B-cell lymphoma 6 (BCL6). Bcl6-in-6 has the potential to study diffuse large B-cell lymphoma (DLBCL). | ||
| M50170 | ARV-393 | PROTAC |
| ARV-393 is an orally active PROTAC degrader targeting BCL6 for studies related to diffuse large B-cell lymphoma. ARV-393 utilizes the ubiquitin-proteasome system to target the degradation of BCL6. | ||
| M21156 | BI-3802 | Bcl-2 |
| BI-3802 is a potent degradation of oncogenic transcription factor BCL6 with strong inhibitory effect on target genes and anti-proliferative effect.BI-3802 inhibits the BTB structural domain of BCL6, corresponding to an IC50 value ≤ 3 nM.BI-3802 has anti-tumor activity. | ||
| M29220 | BCL6-IN-7 | Bcl-2 |
| BCL6-IN-7 is a potent BCL6−corepressor interaction inhibitor. | ||
| M29278 | TP-021 | Bcl-2 |
| BCL6-IN-8c | ||
| TP-021 (BCL6-IN-8c) is a potent and orally active B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor with an IC50 of 0.10 µM in cell-free enzyme-linked immunosorbent assay. | ||
| M29741 | ZW4864 free base | Wnt/beta-catenin |
| ZW4864 (free base) is an orally active and selective β catenin/B-Cell lymphoma 9 protein−protein interaction (β catenin/BCL9 PPI) inhibitor. ZW4864 (free base) inhibits β catenin/BCL9 PPI with a Ki value of 0.76 μM and an IC50 value of 0.87 μM. | ||
| M29742 | ZW4864 | Wnt/beta-catenin |
| ZW4864 is an orally active and selective β catenin/B-Cell lymphoma 9 protein−protein interaction (β catenin/BCL9 PPI) inhibitor. ZW4864 inhibits β catenin/BCL9 PPI with a Ki value of 0.76 μM and an IC50 value of 0.87 μM. | ||
| M41328 | WK499 | Bcl-2 |
| BCL6-IN-10 is a BCL6 inhibitor. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
